Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation
| Image |  |
|---|---|
| Description | scientific article published on 29 December 2016 |
| Author/s |
author: NCRI CLL Sub-Group Claire E. Dearden George Alexander Follows Christopher Fegan Andy C Rawstron Peter Hillmen Dena Howard |
| Publication date | December 29, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |